期刊文献+

高糖培养下大鼠红细胞多元醇代谢变化及二甲双胍的干预作用

Changes of Polyol Pathway Metabolism of Rat Erythrocytes Cultured in High Glucose Medium and Intervention Effect of Metformin
原文传递
导出
摘要 目的:观察高糖培养条件下大鼠红细胞多元醇代谢及脂质氧化的变化及二甲双胍对此的干预作用。方法:用高糖培养大鼠红细胞,测定大鼠红细胞中山梨醇的含量及培养上清液中一氧化氮(NO)含量的变化,并观察加入不同浓度二甲双胍(2×10-5、4×10-6、8×10-7 mol.L-1)处理后对山梨醇和NO含量的影响,同时设立低糖培养的正常对照组进行比较。结果:与正常对照组比较,高糖对照组大鼠山梨醇含量升高、NO含量降低(P<0.01);与高糖对照组比较,加入二甲双胍后能显著降低山梨醇含量并可升高NO的含量(P<0.01或P<0.05)。结论:二甲双胍可通过抑制山梨醇含量的升高及增加NO的水平减轻高糖所致的红细胞损伤。 OBJECTIVE:To observe the changes of lipid oxidation and polyol pathway metabolism of rat erythrocytes cultured in high glucose medium and intervention effect of metformin.METHODS:Rat erythrocytes were cultured in high glucose medium and the content of sorbitol in erythrocytes and the content of NO in culture medium were determined.The effect of metformin at different concentrations(2×10^-5 mol·L^-1,4×10^-6 mol·L^-1,8×10^-7 mol·L^-1)on the level of sorbitol and NO were studied with rat erythrocytes cultured in low glucose medium as normal control.RESULTS:Compared with normal control group,the level of sorbitol in high glucose group was increased while the content of NO was decreased(P〈0.01).Compared with high glucose group,metformin groups had lower level of sorbitol and higher level of NO(P〈0.01 or P〈0.05).CONCLUSION:Metformin can relieve injury of erythrocytes induced by high glucose by inhibiting the increase of sorbitol and decrease of NO.
出处 《中国药房》 CAS CSCD 北大核心 2010年第25期2345-2347,共3页 China Pharmacy
关键词 高糖 红细胞 大鼠 山梨醇 NO 二甲双胍 High glucose Erythrocytes Rat Sorbitol NO Metformin
  • 相关文献

参考文献10

二级参考文献42

  • 1Charles MA,Morange P,Eschwege E, et al .Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects:the BIGPRO1 Study.Bigunaides and the prevention ofthe Risk of Obesity [J]. Diabetes Care ,1998,21:1967.
  • 2Legtenberg RJ, Houston RJ,Oeseburg B, et al. Metformin Improves Functional Rocotional Recovery After Ischemia in Rata[J]. Horm Metab Res ,2002,34:182.
  • 3Jakubowicz DJ, Seppala M, Jakubowicz S, et al . Insulin reduction with metformin incresses luteal phase serum glycolelin and insulin -like growth factor- binding protein 1 concentration and enhances uterine vascularity and blood flow in the polycystic ovary syndrome[ J].J Clin Endocrinol Metab ,2001,86:1126.
  • 4Stadtmauer LA, Toma SK, Riehl BM, et al . Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin -like growth factors[J]. Fertil Steril ,2001,75:505.
  • 5Glueck CJ, Phillips H, Cameron D, et al .Continuing metformin throughout pregnancy in woman with polycystic ovary syndrome appears to safely reduce first - trimester spontaneous abortion: a pilot study[J]. Fertil Steril ,2001,75:46.
  • 6Seli E, Duleba AJ. Should patients with polycystic ovarian syndrome be treated with metformin[J]. Hum Reprod ,2(D2,17:2230.
  • 7Elter K, Imir G, Durmusoglu F. Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol - cyprpterpone acetate in non - obese women with polycymic ovarian syndrome: a randomized controlled study[J]. Hum Reprod ,2002,17:1729.
  • 8Stjth BJ, Woronoff K, Wiemsperger N. Stimulation of the intracellular portion the human insulin receptor by the antidiabetic drug metformin[J]. Biochem pharmaeal, 1995,55:533.
  • 9Stefanovic V,Antic S,Mitic-Zlatkovic M, et al .Reversal of increased lymphocyte PC-1 activity in patients with type-2 diabetes treated with metformin[J]. diabetes metab res rev , 1999,15:400.
  • 10Owen MR, Doran E, Halestrap AP. Evidence that merformin exerts its anti- diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain[J]. Biochem ,2000,15:348 Pt 3:607.

共引文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部